A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders
- PMID: 8554921
- DOI: 10.1016/s8756-3282(95)00150-6
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders
Abstract
The mechanism of action of tiludronate [(4-chlorophenyl)-thiomethylene bisphosphonate] on osteoclastic bone resorption was examined in mouse culture systems. Tiludronate did not inhibit the formation of osteoclast-like multinucleated cells (OCLs) induced by 1 alpha,25-dihydroxyvitamin D3 in cocultures of mouse osteoblastic cells and bone marrow cells. OCLs obtained from cocultures on collagen gel-coated dishes, treated with tiludronate, formed as many resorption pits on dentine slices as those obtained from the control cocultures. However, pit formation by OCLs was dose-dependently inhibited when tiludronate was added directly to the pit formation assay. Other bisphosphonates such as alendronate and etidronate dose-dependently inhibited pit formation according to the in vivo potencies of the respective bisphosphonates to inhibit bone resorption. However, they had no inhibitory effect on the recruitment of OCLs induced by 1 alpha,25-dihydroxyvitamin D3 in the cocultures. When OCLs were placed on dentine slices, they formed the ringed structure of F-actin-containing podosomes and ruffled borders (polarized OCLs) even in the presence of tiludronate. However, the actin rings in OCLs were disrupted by the addition of tiludronate soon after they began to resorb dentine. In contrast, OCLs placed on collagen gel formed neither actin rings nor ruffled borders (nonpolarized OCLs), and showed no response to tiludronate. OCLs formed from the spleen cells of osteosclerotic (oc/oc) mice developed the ringed structure of podosomes, but not ruffled borders, on dentine slices. The actin ring in the oc/oc spleen cell-derived OCLs placed on dentine slices was not disrupted by the addition of tiludronate.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.Bone. 1997 May;20(5):399-404. doi: 10.1016/s8756-3282(97)00025-2. Bone. 1997. PMID: 9145236
-
[Possible mechanism of the specific action of bisphosphonates on osteoclasts].Nihon Rinsho. 2003 Feb;61(2):207-12. Nihon Rinsho. 2003. PMID: 12638209 Review. Japanese.
-
Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts.Bone. 2003 Sep;33(3):443-55. doi: 10.1016/s8756-3282(03)00201-1. Bone. 2003. PMID: 13678787
-
Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts.Bone. 2003 Apr;32(4):341-9. doi: 10.1016/s8756-3282(03)00024-3. Bone. 2003. PMID: 12689676
-
Tiludronate: bone pharmacology and safety.Bone. 1995 Nov;17(5 Suppl):473S-477S. doi: 10.1016/8756-3282(95)00344-9. Bone. 1995. PMID: 8573421 Review.
Cited by
-
Bisphosphonates: effects on osteoblast.Eur J Clin Pharmacol. 2012 Jul;68(7):1013-8. doi: 10.1007/s00228-012-1216-7. Epub 2012 Feb 9. Eur J Clin Pharmacol. 2012. PMID: 22318756 Review.
-
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing.J Clin Med. 2022 Dec 16;11(24):7477. doi: 10.3390/jcm11247477. J Clin Med. 2022. PMID: 36556093 Free PMC article. Review.
-
Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats.J Bone Miner Metab. 2009;27(6):663-72. doi: 10.1007/s00774-009-0090-6. Epub 2009 May 13. J Bone Miner Metab. 2009. PMID: 19436946
-
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals.JBMR Plus. 2020 Sep 29;4(11):e10412. doi: 10.1002/jbm4.10412. eCollection 2020 Nov. JBMR Plus. 2020. PMID: 33210064 Free PMC article.
-
Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.Acta Pharmacol Sin. 2015 Sep;36(9):1085-98. doi: 10.1038/aps.2015.42. Epub 2015 Aug 3. Acta Pharmacol Sin. 2015. PMID: 26235741 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources